Skip to content

Hyperspectral Imaging for the evaluation of microcirculatory response in patients following cardiopulmonary bypass.

Hyperspectral Imaging for the evaluation of microcirculatory response in patients following cardiopulmonary bypass. - HySpiCPB

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030519
Enrollment
25
Registered
2022-11-10
Start date
2022-12-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R57 I25

Interventions

Group 1: Patients with elective operation using a heart-lung-machine will be investigated by hyperspectral imaging.

Sponsors

Univeristätsklinikum Essen, AöR Klinik für Anästhesiologie und Intensivmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Written declaration of consent by the study participant - Age >18 years - Elective cardiac surgery using a cardiopulmonary bypass (heart-lung machine)

Exclusion criteria

Exclusion criteria: - Age < 18 years - Refusal to participate in studies - Known pregnancy - Dark skin type (methodological limitation for cutaneous hyperspectral imaging) - Emergency intervention - Aortic surgery (micro- and macrocirculation often already influenced by the disease itself) - Presence of Extracorporeal Life Support (ECLS) systems assuming hemodynamic functions (vv/vaECMO, Impella, IABP, LVAD) at the time of inclusion

Design outcomes

Primary

MeasureTime frame
The primary outcomes are the correlation of the HSI parameters with the vasoactive-inotropic score (VIS). The VIS quantifies the amount of cardiovascular support and includes the active substances dopamine, dobutamine, epinephrine, milrinon, vasopressin and norepinephrine. The primary outcome parameters are the correlations between the HSI parameters (StO2, NIR or NPI, THI and TWI) after a VOT induced PORH as expression of the cutaneous MRF and the VIS.

Secondary

MeasureTime frame
The secondary outcomes are derived from the secondary goals and include the care data collected as part of standard anaesthesiological therapy.

Countries

Germany

Contacts

Public ContactSven Arends

Universitätsklinikum Essen Klinik für Anästhesiologie und Intensivmedizin

sven.arends@uk-essen.de+20172383515

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026